Clinical Trials in Portland

Showing 9841-9860 of 10,048 trials

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

NCT00510471

The treatment being investigated is a patient- and tumor-specific therapy known as a personalized active immunotherapy. Personalized active immunotherapy is an attempt to use a person's own immune system to combat disease. Sargramostim (a.k.a. GM-CSF) is given together with the personalized active immunotherapy because it may increase the immune system's response and, therefore, aid in the effect of the personalized active immunotherapy. This approach has previously been studied in patients with follicular Non-Hodgkin's lymphoma and other B-cell malignancies. Encouraging efficacy results and a favorable safety profile have been seen to date in these studies.

Non-Hodgkin's Lymphoma

Genitope CorporationStarted May 2007

Los Angeles, California, United States • Denver, Colorado, United States • Indianapolis, Indiana, United States +6 more locations

COMPLETEDPhase 3< 1 mile

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

NCT00064623

The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is effective in treating painful HIV-associated neuropathy.

HIV InfectionsPeripheral Nervous System DiseasesPain

NeurogesX300 participantsStarted Aug 2003

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Berkeley, California, United States +32 more locations

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Find Trials by Condition in Portland

Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

Huperzine A in Alzheimer's Disease

Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NGX-4010 for the Treatment of Postherpetic Neuralgia

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis